Page 40 - Gamida Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tesla Rebalances the Market's Wheels, but Expect Bumps Ahead The electric vehicle company gets included into the S&P 500 before the bell on Monday, and here's where I see good buys -- and some volatility. Dec 18, 2020 | 12:42 PM EST The S&P 500 is trading down around 0.5% at midday, while breadth is running just slightly negative. The action looks like it is primarily driven by the S&P 500 index rebalancing, which is pressuring a large number of stocks as the indexers make room for the addition of Tesla (TSLA) . The Russell 2000 fund  (IWM) has now doubled off the March lows, but sm...

Gamida Cell Announces Launch of Public Offering of Ordinary Shares Gamida Cell Announces Launch of Public Offering of Ordinary Shares Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the launch of a follow-on public offering of its ordinary shares. In addition, Gamida Cell expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the ordinary shares to be sold in the offering on the same terms and conditions. The offering is subject to market and other conditi...

Early data for this company's natural killer cells is drawing lots of attention.